ProShares Ultra Nasdaq Biotechnology $BIB Shares Sold by Toth Financial Advisory Corp

Key Points

• Toth Financial Advisory Corp significantly reduced its holdings in ProShares Ultra Nasdaq Biotechnology (BIB) by 82.3%, selling 4,629 shares during the 2nd quarter.
• IMC Chicago LLC entered a new position in the same ETF, acquiring shares valued at approximately $1,080,000 in the 1st quarter.
• ProShares Ultra Nasdaq Biotechnology announced a quarterly dividend increase to $0.1706 per share, resulting in an annual yield of 1.2%.

Toth Financial Advisory Corp lowered its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) by 82.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 997 shares of the exchange traded fund's stock after selling 4,629 shares during the period. Toth Financial Advisory Corp owned 0.10% of ProShares Ultra Nasdaq Biotechnology worth $46,000 as of its most recent SEC filing.

Separately, IMC Chicago LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth about $1,080,000.

ProShares Ultra Nasdaq Biotechnology Price Performance

BIB stock traded up $0.59 during midday trading on Monday, reaching $58.68. 3,560 shares of the company's stock traded hands, compared to its average volume of 9,027. The business has a 50-day moving average price of $54.28 and a two-hundred day moving average price of $48.79. ProShares Ultra Nasdaq Biotechnology has a fifty-two week low of $33.78 and a fifty-two week high of $68.00. The company has a market capitalization of $59.27 million, a P/E ratio of 20.68 and a beta of 1.63.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, July 1st. Investors of record on Wednesday, June 25th were paid a $0.1706 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.2%. This is a boost from ProShares Ultra Nasdaq Biotechnology's previous quarterly dividend of $0.13. The ex-dividend date was Wednesday, June 25th.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.